Skip to content

Development of an Innovative Method to Extract Cord Blood Stem Cells With High Efficiency

Development of an Innovative Method to Extract Cord Blood Stem Cells With High Efficiency

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07468201
Enrollment
12
Registered
2026-03-12
Start date
2024-04-10
Completion date
2026-04-10
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HSCs Extraction

Brief summary

The present study has the purpose to develop an innovative method for obtaining HSCs with a high yield. HSCs extracted from UCB using the traditional method followed by several steps of centrifugation will be compared to the new method which exploit a new biocompatible liquid, capable to separate the HSCs without causing mechanical stress to cells. The potential of ozone treatment to stimulate cells proliferation will be also assessed. Since ozone has been identified as an adjuvant to sustain cytoprotective pathways increasing cell performance, HSCs obtained from UCB samples will be treated by flowing ozone at low concentrations (between 2 and 20 μg/mL) in a mixture 1:1 with oxygen.

Interventions

the study purpose is to collect between 70 to 200 ml of blood for each donor from both caesarean and natural births, post-partum. The umbilical cord will be clamped, as directed by the surgeon performing the procedure, in two places: close to the placenta and close to the baby.

Sponsors

Fondazione IRCCS Policlinico San Matteo di Pavia
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Healthy women who have signed the informed consent for umbilical cord donation for research purposes

Exclusion criteria

* Women with inability to comply with the requirements of the protocol and presence of viral infections.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of HSCs extractionup to 24 monthsEvaluation of the efficacy of HSCs extraction with a new method which exploit a new biocompatible liquid, capable to separate the HSCs without causing mechanical stress to cells.

Secondary

MeasureTime frameDescription
Effect of ozone treatment on the viability/yield of HSCs.up to 24 monthsThe potential of ozone treatment to stimulate cells proliferation will be assessed
cells recovery after freezing and thawingup to 24 monthsVitality (number of cells) by trypan blue staining and cell counting.

Countries

Italy

Contacts

CONTACTArsenio Spinillo, MD
a.spinillo@smatteo.pv.it0382503792

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026